GILEAD SCIENCES, INC. bought KYTX

February 12, 2024 · Form 4 insider transaction

GILEAD SCIENCES, INC. bought 910,000 shares of Kyverna Therapeutics, Inc. at $22.00 per share, a transaction worth $20.02M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.